TY  - GEN
AU  - Havrdova,E
AU  - Giovannoni,G
AU  - Gold,R
AU  - Fox,R J
AU  - Kappos,L
AU  - Phillips,J Theodore
AU  - Okwuokenye,M
AU  - Marantz,J L
TI  - Effect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing-remitting multiple sclerosis: integrated analysis of the phase III DEFINE and CONFIRM studies
SN  - 1468-1331
PY  - 2017///0605
KW  - Adult
KW  - Delayed-Action Preparations
KW  - Dimethyl Fumarate
KW  - administration & dosage
KW  - Disease Progression
KW  - Female
KW  - Glatiramer Acetate
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Magnetic Resonance Imaging
KW  - methods
KW  - Male
KW  - Middle Aged
KW  - Multiple Sclerosis, Relapsing-Remitting
KW  - diagnostic imaging
KW  - Recurrence
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1111/ene.13272
ER  -